1. Skip to content
  2. Skip to main menu
  3. Skip to more DW sites
ScienceGlobal issues

What's in store for mRNA technology after COVID?

Derrick Wiliams
February 4, 2023

The first vaccines approved during the COVID-19 pandemic were based on a novel platform: messenger RNA. As the field of RNA-based technology matures, researchers are now hopeful it will also prove a powerful weapon in the fight against other diseases.

Skip next section DW's Top Story

DW's Top Story

Forensics carry body bags in a forest near Izyum

Russia's Ukraine violations 'shockingly routine'

Skip next section More stories from DW
Go to homepage